1. A systematic review and meta-analysis of myelosuppression in pediatric patients treated with linezolid for Gram-positive bacterial infections
   Hideo Kato et al, 2021, Journal of Infection and Chemotherapy CrossRef
2. Linezolid vs Vancomycin in Induced Thrombocytopenia
   Dimah Al-Harbi et al, 2022, Infectious Diseases and Therapy CrossRef
3. Evaluation of reporting quality for observational studies using routinely collected health data in pharmacovigilance
   Xiaolu Nie et al, 2018, Expert Opinion on Drug Safety CrossRef
4. Prediction of risk factors for linezolid-induced thrombocytopenia based on neural network model
   Xian Zhao et al, 2024, Frontiers in Pharmacology CrossRef
5. Linezolid-induced thrombocytopenia increases mortality risk in intensive care unit patients, a 10 year retrospective study
   Hyung-Sook Kim et al, 2019, Journal of Clinical Pharmacy and Therapeutics CrossRef
6. Continuous Versus Intermittent Linezolid Infusion for Critically Ill Patients with Hospital-Acquired and Ventilator-Associated Pneumonia: Efficacy and Safety Challenges
   Ahmed E. Abou Abou Warda et al, 2022, Pharmaceuticals CrossRef
7. Treatment of MRSA infections in India: Clinical insights from a Delphi analysis
   Tanu Singhal et al, 2022, Indian Journal of Medical Microbiology CrossRef
8. Effect of linezolid on platelet count in critically ill patients with thrombocytopenia
   Hiroomi Tatsumi et al, 2023, PLOS ONE CrossRef
9. Incidence and Risk Factors for Development of Thrombocytopenia in Patients Treated With Linezolid for 7 Days or Greater
   Alyssa D. Rabon et al, 2018, Annals of Pharmacotherapy CrossRef
10. Detection of Drug-Induced Thrombocytopenia Signals in Children Using Routine Electronic Medical Records
    Xiaolu Nie et al, 2021, Frontiers in Pharmacology CrossRef